Matinas BioPharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access.

CEO

Jerome D. Jabbour

CEOJerome D. Jabbour

Employees

Employees32

Headquarters

Bedminster, New Jersey

HeadquartersBedminster, New Jersey

Founded

2013

Founded2013

Employees

Employees32

MTNB Key Statistics

Market cap

44.67M

Market cap44.67M

Price-Earnings ratio

-1.66

Price-Earnings ratio-1.66

Dividend yield

—

Dividend yield—

Average volume

1.06M

Average volume1.06M

High today

$0.1867

High today$0.1867

Low today

$0.1744

Low today$0.1744

Open price

$0.1828

Open price$0.1828

Volume

1.46M

Volume1.46M

52 Week high

$0.89

52 Week high$0.89

52 Week low

$0.1103

52 Week low$0.1103

MTNB News

TipRanks 5d

Matinas BioPharma announces publication of in vivo efficacy of MAT2203

Matinas BioPharma Holdings announces that MAT2203, its oral formulation of the potent antifungal amphotericin B, demonstrated efficacy compared with placebo in...